EndoChoice Holdings Inc. (NYSE:GI) shot up 4% on Friday . The stock traded as high as $5.21 and last traded at $5.15, with a volume of 52,703 shares changing hands. The stock had previously closed at $4.95.

Several research firms have weighed in on GI. Zacks Investment Research downgraded shares of EndoChoice Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, May 3rd. JPMorgan Chase & Co. began coverage on shares of EndoChoice Holdings in a research note on Wednesday, July 13th. They issued an “overweight” rating for the company.

The firm’s 50 day moving average is $4.65 and its 200-day moving average is $5.08. The company’s market capitalization is $133.96 million.

EndoChoice Holdings (NYSE:GI) last released its earnings results on Wednesday, May 4th. The company reported ($0.68) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.55) by $0.13. The company had revenue of $18.46 million for the quarter, compared to the consensus estimate of $18.34 million. The business’s revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($1.00) earnings per share. On average, analysts predict that EndoChoice Holdings Inc. will post ($2.01) EPS for the current year.

A hedge fund recently raised its stake in EndoChoice Holdings stock. Bank of Montreal Can raised its stake in shares of EndoChoice Holdings Inc. (NYSE:GI) by 25.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 566,845 shares of the company’s stock after buying an additional 115,260 shares during the period. Bank of Montreal Can owned 2.29% of EndoChoice Holdings worth $4,733,000 at the end of the most recent quarter.

Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.